Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

367.40p
   
  • Change Today:
    -4.80p
  • 52 Week High: 415.20
  • 52 Week Low: 331.70
  • Currency: UK Pounds
  • Shares Issued: 8,985m
  • Volume: 12,630,250
  • Market Cap: £33,010m
  • Beta: 0.01

Haleon Overview

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate.

Key Personnel

CEO: Brian McNamara
CFO: Dawn Allen
Independent Non-Executive Director: Blathnaid Bergin
Independent Non-Executive Director: Tracy Jayne Clarke
Independent Non-Executive Director: Nancy Avila
Independent Non-Executive Director: Dame Vivienne Cox
Independent Non-Executive Director: Alan Stewart
Independent Non-Executive Director: Asmita Dubey
Independent Non-Executive Director: Marie-Anne Aymerich
Non-Executive Chairman: Dave Lewis
Senior Independent Non-Executive Director: Manvinder Singh (Vindi) Banga
Non-Executive Dir:

Contact Details

Address: Building 5, First Floor, The Heights, Weybridge, Surrey, United Kingdom, KT13 0NY
Phone: +44 (0) 371 384 2227
Website: https://www.haleon.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100FTSE 350FTSE All-Share
ISIN: GB00BMX86B70

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Haleon Market Data

Currency UK Pounds
Share Price 367.40p
Change Today -4.80p
% Change -1.29 %
52 Week High 415.20
52 Week Low 331.70
Volume 12,630,250
Shares Issued 8,985m
Market Cap £33,010m
Beta 0.01

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.16% below the market average73.16% below the market average73.16% below the market average73.16% below the market average73.16% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Price Trend
26.96% above the market average26.96% above the market average26.96% above the market average26.96% above the market average26.96% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Income
8.01% below the market average8.01% below the market average8.01% below the market average8.01% below the market average8.01% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
12.98% below the market average12.98% below the market average12.98% below the market average12.98% below the market average12.98% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

Haleon Dividends

  Latest Previous
  Final Interim
Ex-Div 24-Apr-25 15-Aug-24
Paid 05-Jun-25 19-Sep-24
Amount 4.60p 2.00p

Trades for 11-Jul-2025

Time Volume / Share Price
16:37 20,000 @ 367.40p
16:36 798,606 @ 367.79p
16:35 83 @ 367.40p
16:35 33 @ 367.40p
16:35 157 @ 367.40p

Haleon Key Personnel

CEO Brian McNamara
CFO Dawn Allen

Top of Page